Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Imaging Chemicals Market Forecast: What Market Value Is Expected By 2030?
The imaging chemicals market has witnessed significant expansion over recent years. Forecasts indicate it is expected to grow from $27.93 billion in 2025 to $29.93 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.2%. This historical growth can be attributed to factors such as the rise of packaging and label printing, the broader scope of medical imaging diagnostics, an increase in the use of chemical developers, persistent demand in textile printing, and the continued availability of conventional imaging chemicals.
The imaging chemicals market is anticipated to experience substantial growth in the coming years. This market is predicted to reach $38.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This projected increase is propelled by factors such as the expanding adoption of digital printing technologies, a heightened demand for sustainable inks and toners, the diversification of healthcare imaging applications, rising investments in innovative specialty chemicals, and an increased regulatory focus on formulations with low volatile organic compounds (VOCs). Dominant trends throughout this period are expected to feature a growing shift towards digital imaging chemicals, a greater need for high-resolution printing inks, extended use in medical diagnostic imaging, the creation of environmentally friendly imaging compositions, and enhanced capabilities of specialty toners.
Download A Free Sample Report For Comprehensive Market Insights:
Imaging Chemicals Market Growth Momentum: Which Factors Are Influencing Demand?
The rising incidence of chronic diseases is anticipated to drive the growth of the imaging chemicals market in the coming years. Chronic diseases, also recognized as non-communicable diseases (NCDs), are prolonged medical conditions marked by their persistent and enduring nature. Imaging chemicals are instrumental in the diagnosis, monitoring, and management of chronic diseases, utilized as contrast agents or tracers across various imaging modalities to enable healthcare professionals to visualize internal structures, identify abnormalities, and assess the progression of these conditions. For instance, in July 2024, the Australian Institute of Health and Welfare (AIHW), an Australia-based government health statistics agency, reported that chronic conditions contributed to 78% of the fatal burden, an increase from previous years. Therefore, the expanding prevalence of chronic diseases is stimulating the imaging chemicals market.
Imaging Chemicals Market Segment Performance And Strategic Opportunities
The imaging chemicals market covered in this report is segmented –
1) By Product Type: Imaging Agents And Toners, Printing Inks, Image Developers
2) By Application: Medical Diagnostics, Packaging And Printing, Textile Processing, Mining, Other Applications
3) By Form: Liquid, Powder
Subsegments:
1) By Imaging Agents And Toners: Liquid Toners, Powder Toners, Imaging Agents For Medical Imaging
2) By Printing Inks: Solvent-Based Inks, Water-Based Inks, UV-Curable Inks, Eco-Friendly Inks
3) By Image Developers: Photographic Developers, Digital Imaging Developers, Chemical Developers For X-Ray Imaging
Imaging Chemicals Market Trends Reshaping Industry Growth
Leading companies within the imaging chemicals market are focusing on creating advanced solutions, including next-generation gadolinium-based contrast agents (GBCAs), to meet the increasing requirement for diagnostic imaging that is safer, more effective, and provides enhanced resolution. These technologically sophisticated contrast agents offer improved relaxivity and demand smaller doses compared to conventional formulations, thereby mitigating safety concerns related to gadolinium exposure and simultaneously enabling sharper, more accurate MRI visualizations. An example of this is the launch of the Elucirem (gadopiclenol) injection by Guerbet Group, a pharmaceutical and medical imaging company based in France, in February 2023. This cutting-edge GBCA from Guerbet delivers the highest relaxivity within the magnetic resonance imaging (MRI) field and is suitable for use by adults and children aged 2 years and older. Elucirem needs only half the gadolinium dosage of conventional non-specific GBCAs, thereby easing the concerns of medical professionals regarding gadolinium exposure. The Elucirem (gadopiclenol) injection facilitates the detection and visualization of lesions exhibiting abnormal vascularity within the central nervous system (brain, spine, and related tissues) and across the entire body (head and neck, chest, stomach, pelvis, and musculoskeletal system).
Imaging Chemicals Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the imaging chemicals market are Eastman Kodak Company, Agfa-Gevaert NV, Altana AG, BASF SE, Clariant Chemical Company, DIC Corporation, Dow Chemical Company, Flint Group S.A., FUJIFILM Holdings Corporation, Hubergroup Deutschland GmbH, Kao Corporation, Kodak Alaris Inc., Qingdao Scienoc Chemical Co., Sakata Inx Corp., Siegwerk Druckfarben AG & Co. KGaA, T&K TOKA Corporation, Toyo Ink SC Holdings Co. Ltd., Wikoff Color Corporation, Evonik Industries AG, Merck Co. & KGaA
Access The Complete Imaging Chemicals Market Report:
Imaging Chemicals Market Regional Analysis And Leading Geography
Asia-Pacific was the largest region in the imaging chemicals market in 2025. The regions covered in the imaging chemicals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.